change from semaglutide to tirzepatide Switching between weight-loss medications Switching from Semaglutide to Tirzepatide:

Long-term PPI use carries known risks including reduced B12 and magnesium absorption, increased fracture risk, and potential alterations in gut microbiota diversity

Copper peptides can be applied topically to the scalp to promote faster healing and reduce inflammation, which may lead to a more comfortable recovery period for the patient

The connection between delayed gastric emptying and altered intestinal movement highlights that these symptoms are not unexpected complications but rather a known part of how the therapy functions

Book a consultation today to see how we can help reduce side effects and improve results

Pregnancy and lactation : Semaglutide is generally not recommended during pregnancy (due to its unknown side effects on fetal development) and breastfeeding